Introduction {#s1}
============

Amphibians are attractive experimental models for elucidating the mechanisms underlying animal development. However, the functional analysis of genes is limiting in amphibians as compared with those of other model animals, because there has been no way to efficiently introduce targeted gene disruption in eggs and germ cells. Therefore, innovation of targeted and heritable mutagenesis techniques has been long wished in the research area.

To generate gene knockout organisms, gene editing using transcription activator-like effector nucleases (TALENs) technique has been introduced to various model animals including worm, cricket, zebrafish, and rat ([@b17]; [@b4]; [@b15]; [@b13]; [@b16]). Recently, it has been reported that targeted gene disruption by TALENs succeeded with high efficiency in *Xenopus tropicalis* and *Xenopus laevis* ([@b7]; [@b5]). TALENs consist of two functional domains: a customized repeat array of TAL DNA-binding domains that recognize a specific DNA sequence and nuclease domain of FokI, a class IIS restriction enzyme ([@b8]). A pair of the customized TALENs binds to its target sequence, allowing FokI nuclease domains to dimerize and introduce double-strand breaks (DSBs). When DSBs are efficiently repaired by error-prone non-homologous end-joining (NHEJ) in cells, insertion, deletion, and insertion and/or deletion frequently occur at the TALEN-mediated DSB site. Subsequently, NHEJ repair leads to target gene disruption by frame shift. Therefore, the TALEN technique readily modifies target loci and disrupts gene functions. However, this technique requires optimization for each organism. For example, to increase the efficiency of TALEN *in vivo*, multiple TALEN scaffolds have recently been improved and examined with some modifications: truncation of N- and C-termini, hetero- or homodimers of FokI nuclease domains, and backbone vectors ([@b8]; [@b9]; [@b1]).

In this study, utilizing recent information, we generated modified high-efficiency TALENs based on the Golden Gate Method ([@b2]; [@b12]). Here, we examine the efficiency of gene disruption by our modified TALENs in *X. laevis* early embryogenesis, using two endogenous genes, *tyrosinase* and *pax6*, involved in pigmentation and eye formation.

Materials and Methods {#s2}
=====================

Generation of TALENs {#s2a}
--------------------

Pairs of TALENs against *tyr* and *pax6* were generated using the Golden Gate TALEN kit and TAL effector Kit (Addgene) ([@b2]) with some modifications ([@b12]). TALEN target sites were determined by TAL effector Nucleotide Targeter Ver. 2.0 ([@b3]). After construction of TALE arrays against each gene, they were subcloned into a destination vector based on pcDNA3.1 containing the truncated N- and C-terminal domains of TALE (+153/+47) and wild-type FokI nuclease domain derived from pTAL3 ([@b2]; [@b9]; [@b12]). We screened for a more efficient TALENs set by the Single Stranded Annealing (SSA) assay ([@b10]). TALEN mRNAs were synthesized by mMessage mMachine T7 Ultra Kit (Life Technologies) after linearization by *Xma*I (NEB).

Manipulation of *Xenopus laevis* eggs {#s2b}
-------------------------------------

Fertilized eggs were obtained from breeding pairs of *X. laevis* injected with human chorionic gonadotropin ([@b14]). Eggs were dejellyed with 2% cysteine treatment and then were moved into 3% Ficoll in 0.3× MMR. Approximately 550 pg of each right and left or 1100 pg of only right TALENs mRNA were injected into eggs at the one-cell stage with 4.6 nl volume using Nano-ject II (Drummond). Injected embryos were cultured in 0.1× MMR containing gentamycin from the blastula to the swimming tadpole stages at 18°C. The animals were handled in accordance with the guidelines of Hiroshima University for the use and care of experimental animals.

Mutation analysis {#s2c}
-----------------

Genomic DNA samples of individual embryos were extracted with DNeasy kit (Qiagen). Genomic regions containing the TALEN target site of each gene were amplified with specific primer sets (described in [supplementary material Table S1](http://bio.biologists.org/lookup/suppl/doi:10.1242/bio.20133855/-/DC1)). PCR was carried out with KOD FX Neo or LA Taq (ToYoBo and TaKaRa, respectively). To examine the efficiency of target mutations in the injected embryos, we performed restriction enzyme digestion of PCR products using HinfI (TaKaRa) or Hpy188I (NEB). To confirm the presence of TALEN-mediated mutations, PCR products were subcloned into pCR2.1/TOPO (Life Technologies), and then positive clones were selected by colony PCR. Colony PCR products were sequenced using BigDye Terminator Ver. 3.1 (Life Technologies).

Results and Discussion {#s3}
======================

Tyrosinase gene disruption by TALENs {#s3a}
------------------------------------

To examine whether our TALENs effectively induce targeted gene disruption in *X. laevis*, we generated two TALEN sets against tyrosinase (*oculocutaneous albinism IA*; *tyr*) involved in melanin synthesis and is specifically expressed in retinal pigment epithelium (RPE) and melanophores ([@b6]). If this gene is effectively disrupted by TALENs, we can visually identify *tyr* phenotypes as albino. *X. laevis* has an allotetraploid genome, but only one *tyr* cDNA sequence is deposited in the public databases, NCBI Refseq and Xenbase (<http://www.xenbase.org/common>). Two pairs of TALENs against the first exon of the *tyr* locus were generated, and we selected a set with higher activity by the SSA assay ([@b10]). Next, we injected 550 pg of each right and left TALEN pair (TALEN-R/L) mRNA into the fertilized eggs at the one-cell stage. As a negative control, we also injected 1100 pg of the right TALEN mRNA (TALEN-R) only. As expected, many albino phenotypes were observed in the *tyr* TALEN-R/L-injected embryos, while there was no change of pigmentation in both the TALEN-R-injected and uninjected control embryos ([Fig. 1A](#f01){ref-type="fig"}). In particular, pigmentation in the RPE was effectively lost by *tyr* TALENs. Similar to previous data in *X. tropicalis*, *tyr* TALENs effectively induced albinism in the RPE of F0 embryos ([@b5]). We confirmed the targeted gene disruption in the phenotypes by genomic PCR with restriction enzyme digestion. The genomic region containing *tyr* TALEN site was amplified by PCR with a specific primer set ([Fig. 1B](#f01){ref-type="fig"}, upper; [supplementary material Table S1](http://bio.biologists.org/lookup/suppl/doi:10.1242/bio.20133855/-/DC1)). PCR products of TALEN-R/L-injected embryos appear as a doublet compared with those of TALEN-R-injected and uninjected embryos, possibly due to heteroduplex formation of mutant and normal alleles ([Fig. 1B](#f01){ref-type="fig"}, middle). The spacer region between TALEN target sequences contains the HinfI recognition site. Therefore, if this site is disrupted, the restriction enzyme cannot recognize and cut it. Most PCR product of TALEN-R/L-injected embryos became resistant to HinfI; in contrast, those of TALEN-R-injected and uninjected samples were almost completely digested ([Fig. 1B](#f01){ref-type="fig"}, lower). Moreover, a PCR sample from one of the phenotypes was subcloned and subjected to DNA sequencing analysis. The rate of *tyr* mutation was 50% (10 mutants/20 total clones; [Fig. 1C](#f01){ref-type="fig"}). The same mutation rate was also obtained from genomic PCR clones of the pooled phenotypes ([supplementary material Fig. S1](http://bio.biologists.org/lookup/suppl/doi:10.1242/bio.20133855/-/DC1)). In addition, 30% of total mutations were in-frame mutations and may not affect enzymatic activity of *tyr*. Phenotypes could be divided into three groups: severe phenotypes showed loss of pigmentation in RPE; moderate phenotypes showed mosaic but more than half loss of pigmentation in RPE; weak phenotypes showed slight loss of pigmentation in RPE ([Fig. 2A,B](#f02){ref-type="fig"}). More than 70% of the TALEN-R/L-injected embryos show some pigment disruption. Patchy loss of pigmentation was observed, suggesting that mosaic but biallelic *tyr* disruption by frameshift in the pigmentless RPE and melanophores.

![Disruption of tyrosinase (*tyr*) in TALEN mRNA-injected embryos.\
(**A**) Phenotypes of *tyr* TALEN-injected embryos: Uninjected control embryos; TALEN-R, embryos injected with 1100 pg right *tyr* TALEN mRNA; TALEN-R/L, embryos injected with 550 pg of each right and left *tyr* TALEN mRNA. Injected embryos were reared to the hatching stage. (**B**) Detection of *tyr* mutations by genomic PCR and digestion with a restriction enzyme. Five embryos each were collected from the three experimental groups (Uninjected, TALEN-R, and TALEN-R/L). Upper image: a schematic drawing of *tyr* genomic PCR product. Genomic DNA of each embryo was prepared and then was subjected to PCR with a specific primer set for amplification containing the *tyr* TALEN target site. HinfI site is located on spacer sequence of the TALEN site. Middle image: a gel electrophoresis image of *tyr* genomic PCR products. Lower image: HinfI-digestion of PCR products for detecting *tyr* mutations. PCR products were purified and then were digested by HinfI. HinfI fragments are divided into 131 and 119 bp. M means 100 bp ladder marker. (**C**) Sequences and frequencies of *tyr* mutations. PCR product from the TALEN-R/L-injected embryo (asterisk in panel A) was subcloned and was subjected to DNA sequencing analysis. Mutant sequences were aligned to that of wild type. Sequence of wild-type allele is shown at the top. Yellow boxes indicate *tyr* TALEN target site. Gaps generated by deletion are shown as blue dashes. A substitution is shown as an underlined blue character. Types and frequencies of each mutation (deletion and insertion) are shown at the right of the panel.](bio-02-05-448-f01){#f01}

![Phenotypes of *tyr* TALEN-injected embryos.\
Embryos were divided into four groups according to their phenotypes. (**A**) Representative phenotypes: Severe, near complete loss of pigmentation in retina pigmented epithelium (RPE); Moderate, more than half loss of pigmentation in RPE; Weak, less than half loss of pigmentation in RPE; Normal, no alteration of pigmentation. (**B**) Percentage of phenotypes in the three experimental groups, Uninjected, TALEN-R, and TALEN-R/L. Total numbers of individuals in this experiment are shown at the top of each graph.](bio-02-05-448-f02){#f02}

Our results are slightly different from that of the previous report in *X. tropicalis* ([@b5]); TALEN mediated *tyr* disruption in *X. tropicalis* seemed to be more efficient than in *X. laevis*. This disparity may reflect differences of species or TALEN platforms. Another key issue for applying TALENs in *Xenopus* is toxicity. In zebrafish, heterodimeric TALENs show less toxic than homodimeric TALENs ([@b1]). However, in some cases, introduction of a high dose of TALEN mRNA with heterodimer type FokI, (500∼800 pg) exhibits high toxicity and rate of developmental defects in *X. tropicalis* ([@b7]). On the other hand, our results and Ishibashi et al. demonstrate that even if a high dose of TALEN mRNA is injected, its toxicity and induction of developmental defects are low in *X. laevis* and *X. tropicalis* ([@b5]). Actually, most of the TALEN-injected embryos developed into tadpoles and adults with albinism ([supplementary material Fig. S2](http://bio.biologists.org/lookup/suppl/doi:10.1242/bio.20133855/-/DC1)). Therefore, there is room for further optimization of TALEN platforms to increase the efficiency and decrease toxicity in *Xenopus*.

*pax6* gene disruption by TALENs {#s3b}
--------------------------------

Next, we generated TALEN sets against *pax6* involved in eye lens formation ([@b11]). Due to its allotetraploid genome, there are two paralogs, *pax6a and pax6b*, in *X. laevis* in the public databases. We generated a pair of TALENs that recognize the conserved sequences of the putative third exon between *pax6a* and *pax6b*. We validated the activity of this TALEN set by SSA assay and injected their mRNA into the fertilized eggs. Expectedly, many phenotypes showed disturbance of eye development in the TALEN-R/L mRNA-injected embryos ([Fig. 3A](#f03){ref-type="fig"}). The phenotypes closely resemble with those of *pax6* morphants ([@b11]), suggesting that injection of TALENs recapitulates the knockdown of *pax6* by antisense morpholinos. Also, *pax6* protein was greatly reduced in the TALEN-R/L-injected embryos as compared with control siblings ([supplementary material Fig. S3](http://bio.biologists.org/lookup/suppl/doi:10.1242/bio.20133855/-/DC1)). We also confirmed the targeted gene disruption by genomic PCR with restriction enzyme digestion ([Fig. 3B](#f03){ref-type="fig"}). Genomic region containing *pax6* TALEN site was amplified with a specific primer set ([Fig. 3B](#f03){ref-type="fig"}, upper). PCR products of the TALEN-R/L-injected embryos tend to be slightly lower molecular weight than those of the TALEN-R-injected and uninjected embryos, possibly due to deletions mediated by TALENs (see other experimental examples; [supplementary material Fig. S4](http://bio.biologists.org/lookup/suppl/doi:10.1242/bio.20133855/-/DC1)). PCR products from TALEN-R and uninjected control samples were completely digested by Hpy188I. In contrast, TALEN-R/L PCR products could not be digested, indicating that the spacer sequence containing Hpy188I site is mutated. To confirm the mutations by *pax6* TALENs, we carried out DNA sequencing analysis. Surprisingly, sequences of all clones exhibited deletion mutations in a TALEN-R/L-injected embryo (22 mutants/22 total clones; [Fig. 3C](#f03){ref-type="fig"}). The similar result was obtained about the high mutation rate from the pooled phenotypes ([supplementary material Fig. S5](http://bio.biologists.org/lookup/suppl/doi:10.1242/bio.20133855/-/DC1)). Interestingly, both *pax6a* and *pax6b* mutation was confirmed, suggesting that the TALENs almost perfectly introduced bi-allelic and paralogous mutation in *X. laevis*. The TALEN target site is located at the sequence encoding linker region in paired domain of PAX6, which is a crucial domain for DNA binding ([@b18]). Therefore, even if deletions and insertions occur in multiples of 3 bp, in-frame mutations of *pax6* by TALENs could perturb eye formation. Phenotypes could be divided into three groups: severe phenotypes showed loss of eyes; moderate phenotypes showed deformation of eyes; weak phenotypes showed small eyes ([Fig. 4A](#f04){ref-type="fig"}). More than 85% of the TALEN-R/L-injected embryos showed some perturbation of eye formation, whereas most of TALEN-R-injected and uninjected embryos presented normal phenotypes ([Fig. 4B](#f04){ref-type="fig"}). *pax6* TALENs also exhibited low toxicity in injected embryos. Rate of developmental defects is within 20% in the TALEN-R- and TALEN-R/L-injected embryos.

![Disruption of *pax6* in the TALEN mRNA-injected embryos.\
(**A**) Phenotypes of *pax6* TALEN-injected embryos: TALEN-R, embryos injected with 1100 pg right *pax6* TALEN mRNA; TALEN-R/L, embryos injected with 550 pg of each right and left *pax6* TALEN mRNA. Injected embryos were reared to the hatching stage. Upper image: low magnification of each experimental group. Lower image: high magnification of representative phenotypes from TALEN-R- and TALEN-R/L-injected embryos noted by squares in the upper image. (**B**) Detection of *pax6* mutations by genomic PCR and digestion with a restriction enzyme. One embryo was collected from each of the three experimental groups (asterisks in panel A): Uninjected, TALEN-R, and TALEN-R/L. Upper image: a schematic drawing of *pax6* genomic PCR product. Genomic DNA of each embryo was prepared and then was subjected to PCR with a specific primer set for amplification containing the *pax6* TALEN target site. Hpy188I site is located on spacer sequence of the TALEN site. Left image: a gel electrophoresis image of *pax6* genomic PCR products. Right image: Hpy188I-digestion of PCR products for detecting *pax6* mutations. PCR products were purified and then digested by Hpy188I. Hpy188I fragments are divided into 101 and 54 bp. M means 100 bp ladder marker. Uninjected indicates uninjected control embryo. (**C**) Sequences and frequencies of *pax6* mutation by TALENs. PCR product from the TALEN-R/L-injected embryo (asterisk in panel A) was subcloned and was subjected to DNA sequencing analysis. Mutant sequences were aligned to those of wild type. Sequences of *pax6a* and *pax6b* wild-type alleles are shown at the top. Yellow boxes indicate *pax6* TALEN target site. Gaps generated by deletion are shown as blue dashes. Types and frequencies of each mutation (deletion and insertion) are shown at the right of the panel. Paralogous substitutions between *pax6a* and *pax6b* are highlighted in green.](bio-02-05-448-f03){#f03}

![Phenotypes of *pax6* TALEN-injected embryos.\
Embryos were divided into four groups according to their phenotypes. (**A**) Representative phenotypes: Severe, near complete loss of eyes; Eye deformation, embryos with deformed eyes; Small eyes, embryos with apparently small eyes as compared with the Uninjected and TALEN-R-injected embryos; Normal, no alteration of eye formation and size. (**B**) Percentage of phenotypes in the three experimental groups, Uninjected, TALEN-R, and TALEN-R/L. Total numbers of individuals in this experiment are shown at the top of each graph.](bio-02-05-448-f04){#f04}

In this research, we demonstrate that our engineered TALENs effectively disrupt target genes with low toxicity in *X. laevis* embryos. In addition, our results also suggest that TALENs can introduce not only bi-allelic but also paralogous genome editing in *X. laevis*, where most genes are duplicated due to polyploidization. Thus, our TALEN architecture is suitable for *X. laevis* research. TALEN specificity seems to be high; however, there are problems regarding off-target effects when uncharacterized genes are analyzed. Then rescue experiments regarding genes of interest using mRNA injection and transgenic techniques will be needed for precise analysis of gene function in *Xenopus*. We expect that targeted gene disruption by TALENs will provide an alternative method to analyze functions of genes comparable to antisense morpholino in *X. laevis* and *X. tropicalis* research.
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